Article
ACE2 expression in PBMC and plasma markers of vasculopathy and fibrosis during early COVID – implications for post-COVID conditions
2023-10-05
Abstract excerpt
<h4>Background: </h4> Severe COVID is uncommon, restricted to 19% of the population. In response to the first virus wave (alpha variant of SARS-CoV-2), we investigated whether variable expression of angiotensin converting enzyme 2 (ACE2) in blood might identify this difference in risk. <h4>Methods: </h4> The study was IRB-approved, comparing patients hospitalized with severe COVID to healthy controls. A single bl...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 40eb9bb1-2ae6-5aab-aae3-8e96f1485c5b
- DOI
- 10.21203/rs.3.rs-3374090/v1
